Source study found

Story checked

Autism linked to 14-year gap in life expectancy (opens in a new tab)

medicalxpress.com · 2026-09-10

Short answerEvidenceSource

Short answer

Not supported

Not supported.

One claim goes further than the study. 5 other points were not covered by the paper.

1 overstated
5 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Autism linked to 14-year gap in life expectancy

medicalxpress.com · 2026-09-10

The story’s checkable claims.

Read the original story

NewsLink checks it

Not supported

One claim overstates the study. Five claims the study doesn't address.

1 overstated
5 not covered

Open claim evidence

The source study

Autism Spectrum Disorder and Life Expectancy Among Medicaid Beneficiaries

JAMA Network Open · 2026

Open source record

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedPeople with autism spectrum disorder (ASD) in the United States face a 14-year deficit in life expectancy, according to a new study by researchers at Columbia University Mailman School of Public Health and University of Colorado Anschutz.View evidenceHide evidence

As stated14-year deficit

Why this verdict

The supplied abstract-level profile supports a study of life expectancy and excess mortality among Medicaid beneficiaries with ASD, not all people with ASD in the United States. The headline framing generalizes the Medicaid-specific evidence to the broader U.S. ASD population; the stated 14-year magnitude is also not verifiable from the abstract-level profile because no numerical estimates are provided.

Study evidence

The study estimates life expectancies for Medicaid beneficiaries with ASD and quantifies excess mortality compared with Medicaid beneficiaries without ASD; it also examines causes of death associated with excess mortality.

Claim 2 of 6Not coveredThe study provides one of the first large-scale estimates of age-specific death rates and life expectancy among people with ASD, and the findings are published in JAMA Network Open.View evidenceHide evidence

As statedone of the first large-scale estimates

Why this verdict

The profile supports that the paper estimates life expectancy and excess mortality among Medicaid beneficiaries with ASD. However, the abstract-level profile does not verify the novelty claim that it is 'one of the first large-scale estimates,' nor does it provide enough publication-detail evidence beyond the supplied DOI context to fully substantiate the venue statement as framed.

Study evidence

Claim 3 of 6Not coveredUsing Transformed Medicaid Statistical Information System and Children's Health Insurance Program Statistical Information System data linked to the National Death Index, the researchers analyzed 2,048,046 Medicaid-enrolled individuals with ASD from 2000 through 2020.View evidenceHide evidence

As stated2,048,046 individuals; 2000 through 2020

Why this verdict

The profile supports use of Medicaid administrative/eligibility data linked to mortality or death records in general. It does not specify the named T-MSIS/CHIP systems, National Death Index linkage, sample size of 2,048,046, or the 2000-2020 time frame at abstract depth.

Study evidence

Claim 4 of 6Not coveredLife expectancy at birth for Medicaid beneficiaries with ASD was 64.9 years, 5.6 years shorter than for the overall Medicaid population and 13.8 years shorter than for the U.S. general population.View evidenceHide evidence

As stated64.9 years; 5.6 years shorter; 13.8 years shorter

Why this verdict

The profile supports that life expectancy was estimated for Medicaid beneficiaries with ASD and compared with Medicaid beneficiaries without ASD. It does not provide the numerical life expectancy of 64.9 years, the 5.6-year Medicaid gap, or the 13.8-year U.S. general-population comparison in the supplied abstract-level evidence.

Study evidence

Claim 5 of 6Not coveredMedicaid beneficiaries with ASD had a 44% higher mortality risk than other Medicaid beneficiaries, with excess mortality especially noted for influenza, malnutrition, pneumonitis, non-transport accidents, drowning and pneumonia.View evidenceHide evidence

As stated44% higher mortality risk

Why this verdict

The profile supports that excess mortality and causes of death associated with excess mortality were examined. It does not provide the 44% higher mortality estimate or the specific excess-cause list of influenza, malnutrition, pneumonitis, non-transport accidents, drowning, and pneumonia at abstract depth.

Study evidence

Study evidence

The abstract reports that the study examines causes of death associated with excess mortality among Medicaid beneficiaries with ASD, but provides no cause-specific results, effect sizes, or detailed cause distributions in the abstract.

Claim 6 of 6Not coveredThe article says autistic women experienced a greater life expectancy deficit than autistic men, largely associated with higher rates of psychiatric comorbidities and related excess mortality, and that much of the excess mortality may be avoidable through improved social support, primary care, and home- and community-based services.View evidenceHide evidence

As statedgreater life expectancy deficit; much of the excess mortality is avoidable

Why this verdict

The supplied abstract-level profile does not report sex-specific life-expectancy deficits, psychiatric comorbidity explanations, or intervention/avoidability conclusions involving social support, primary care, or home- and community-based services. These claims may come from full text or commentary, but they are not verifiable from the supplied profile.

Study evidence

Study evidence

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

At abstract depth, the supplied paper profile contains no numerical effect estimates, life-expectancy values, sample size, exact study years, or cause-specific result estimates.
The story presents precise numbers and detailed cause-specific claims, but the supplied abstract-level profile states that these numerical and cause-specific results are not available in the abstract evidence.
From Cross-sectional analysis of administrative Medicaid data; Cross-sectional cause-of-death analysis (secondary data)
Because the study is observational and cross-sectional, temporal or causal interpretations and intervention/avoidability claims are limited and may be affected by residual confounding.
The story mostly frames mortality differences as associations, but its avoidability language about improved support, primary care, and community-based services goes beyond what the abstract-level profile can support and does not mention residual confounding or causal limits.
From Cross-sectional analysis of administrative Medicaid data; Cross-sectional cause-of-death analysis (secondary data)

4 things the story did carry across

The paper's central population is Medicaid beneficiaries with ASD, with comparisons to Medicaid beneficiaries without ASD; generalizability beyond Medicaid beneficiaries is limited.
The study is observational/cross-sectional secondary-data research using administrative Medicaid records linked to mortality data.
The paper's primary contribution is estimating life expectancy and quantifying excess mortality among Medicaid beneficiaries with ASD versus those without ASD.
The paper's secondary contribution is examining causes of death associated with excess mortality among Medicaid beneficiaries with ASD.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataEstimate life expectancy among Medicaid beneficiaries with autism spectrum disorder (ASD) and quantify excess mortality compared with Medicaid beneficiaries without ASD.Cross-sectional analysis of administrative Medicaid dataExpand

In plain English

Cross-sectional analysis of Medicaid administrative data estimating life expectancy and quantifying excess mortality among beneficiaries with autism spectrum disorder (ASD) versus beneficiaries without ASD; the study also examines causes of death contributing to any excess mortality.

Key findings

The study estimates life expectancies for Medicaid beneficiaries with ASD and quantifies excess mortality compared with Medicaid beneficiaries without ASD; it also examines causes of death associated with excess mortality.

What this piece can’t prove

Summary is based solely on the abstract; full-text methodological and result details are not available in the supplied evidence.
Cross-sectional analysis of administrative records limits ability to assess temporal or causal relationships and may be susceptible to residual confounding if not fully adjusted.

2 further details could not be confirmed from the summary.

2secondary dataCharacterize causes of death associated with excess mortality among Medicaid beneficiaries with ASD (cause-of-death distribution/patterns).Cross-sectional cause-of-death analysis (secondary data)Expand

In plain English

Cross-sectional, secondary-data analysis of causes of death among Medicaid beneficiaries with autism spectrum disorder (ASD) aiming to characterize cause-of-death patterns contributing to excess mortality; the abstract states the study examines life expectancies and causes of death but does not report cause-specific results or effect estimates in the abstract.

Key findings

The abstract reports that the study examines causes of death associated with excess mortality among Medicaid beneficiaries with ASD, but provides no cause-specific results, effect sizes, or detailed cause distributions in the abstract.

What this piece can’t prove

Summary is based solely on the article abstract; full-text methods and results (cause-specific findings) are not available here.
Cross-sectional, observational design using administrative death records may be subject to misclassification of cause of death and limited covariate adjustment (not detailed in abstract).
Findings, as described, are specific to Medicaid beneficiaries and may not generalize to non-Medicaid populations.

Finally, the search trail

Method layer